Evidence map›Paper›PMID 22436698›Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2012

Serotonin 5-HT2C receptor-mediated inhibition of the M-current in hypothalamic POMC neurons.

T A Roepke, A W Smith, O K Rønnekleiv, M J Kelly

Abstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. 5-HTNutrients · 2023
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Serotonergic afferents from the dorsal raphe decrease the excitability of pyramidal neurons in the anterior piriform cortex.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

T A RoepkeDept. of Physiology & Pharmacology,Oregon Health & Science University, Portland, OR 97239-3098, USA.
A W Smith
O K Rønnekleiv
M J Kelly
Oregon Health & Science University · USOregon National Primate Research Center · US

Funding

Sex Differences in the Control of FeedingR01DK068098 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI KELLY, MARTIN JEFFREY, RØNNEKLEIV, OLINE KARIN · 2005 to 2024
$7.1M
BETA ENDORPHIN NEURONS AND THE CONTROL OF HOMEOSTASISR01NS038809 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI KELLY, MARTIN JEFFREY · 1999 to 2018
$6.8M
Estrogen Modulation of Bursting Activity in GnRH NeuronsR01NS043330 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI RØNNEKLEIV, OLINE KARIN · 2004 to 2019
$5.5M
Beta Endorphin Neurons and the Control of HomeostasisR56NS038809 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI KELLY, MARTIN JEFFREY · 2009 to 2009
$481k
Crosstalk between Estrogen and Metabolic Hormone Signaling in Kisspeptin NeuronsR56DK068098 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI KELLY, MARTIN JEFFREY, RØNNEKLEIV, OLINE KARIN · 2020 to 2020
$262k
Estrogen regulation of channels involved in the control of energy homeostasisK99DK083457 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI ROEPKE, TROY ADAM · 2009 to 2010
$180k
NIDDK NIH HHS DK-68098NIDDK NIH HHS K99 DK083457NIDDK NIH HHS K99 DK-83457NIDDK NIH HHS R01 DK068098NIDDK NIH HHS R56 DK068098NINDS NIH HHS NS-38809NINDS NIH HHS NS-43330NINDS NIH HHS R01 NS038809NINDS NIH HHS R01 NS043330NINDS NIH HHS R56 NS038809
6 · The paper itself

Abstract

Hypothalamic proopiomelanocortin (POMC) neurons are controlled by many central signals, including serotonin. Serotonin increases POMC activity and reduces feeding behavior via serotonion [5-hydroxytryptamine (5-HT)] receptors by modulating K(+) currents. A potential K(+) current is the M-current, a noninactivating, subthreshold outward K(+) current. Previously, we found that M-current activity was highly reduced in fasted vs. fed states in neuropeptide Y neurons. Because POMC neurons also respond to energy states, we hypothesized that fasting may alter the M-current and/or its modulation by serotonergic input to POMC neurons. Using visualized-patch recording in neurons from fed male enhanced green fluorescent protein-POMC transgenic mice, we established that POMC neurons expressed a robust M-current (102.1 ± 6.7 pA) that was antagonized by the selective KCNQ channel blocker XE-991 (40 μM). However, the XE-991-sensitive current in POMC neurons did not differ between fed and fasted states. To determine if serotonin suppresses the M-current via the 5-HT(2C) receptor, we examined the effects of the 5-HT(2A)/5-HT(2C) receptor agonist 2,5-dimethoxy-4-iodoamphetamine (DOI) on the M-current. Indeed, DOI attenuated the M-current by 34.5 ± 6.9% and 42.0 ± 5.3% in POMC neurons from fed and fasted male mice, respectively. In addition, the 5-HT(1B)/5-HT(2C) receptor agonist m-chlorophenylpiperazine attenuated the M-current by 42.4 ± 5.4% in POMC neurons from fed male mice. Moreover, the selective 5-HT(2C) receptor antagonist RS-102221 abrogated the actions of DOI in suppressing the M-current. Collectively, these data suggest that although M-current expression does not differ between fed and fasted states in POMC neurons, serotonin inhibits the M-current via activation of 5-HT(2C) receptors to increase POMC neuronal excitability and, subsequently, reduce food intake.

Indexed as

AmphetaminesAnimalsAnthracenesCalcium Channel BlockersFastingHypothalamusKCNQ Potassium ChannelsMaleMiceMice, TransgenicNeuronsPatch-Clamp TechniquesPiperazinesPotassium Channel BlockersPro-OpiomelanocortinReceptor, Serotonin, 5-HT2C10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone1-(3-chlorophenyl)piperazine4-iodo-2,5-dimethoxyphenylisopropylamine8-(5-(5-amino-2,4-dimethoxyphenyl)-5-oxopentyl)-1,3,8-triazaspiro(4.5)decane-2,4-dioneAmphetaminesAnthracenesCalcium Channel BlockersKCNQ Potassium ChannelsPiperazinesPotassium Channel BlockersPro-OpiomelanocortinReceptor, Serotonin, 5-HT2CSerotonin AntagonistsSerotonin Receptor AgonistsSpiro CompoundsSulfonamides

Identifiers

PMID22436698
PMCPMC3378066
OpenAlexW2149225145

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.